Cytokinetics (CYTK) Operating Expenses (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Operating Expenses of $203.0 million for Q1 2026, up 29.11% year-over-year from $157.2 million in Q1 2025, and up 3.49% quarter-over-quarter from $196.1 million in Q4 2025.
Cytokinetics (CYTK) Operating Expenses (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Operating Expenses for 17 consecutive years, with $203.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 29.11% year-over-year to $203.0 million; the TTM figure through Mar 2026 stood at $746.1 million (up 27.56% YoY), while the FY2025 annual figure was $700.3 million, up 26.24% from the prior year.
- Operating Expenses advanced to $203.0 million in Q1 2026 per CYTK's latest filing, from $196.1 million in the prior quarter.
- Across five years, Operating Expenses topped out at $203.0 million in Q1 2026 and bottomed at $79.0 million in Q1 2022.
- Historically, Operating Expenses has averaged $140.0 million across 5 years, with a median of $129.1 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 73.22% — and 2024, when it fell 1.56%.
- Cytokinetics' Operating Expenses stood at $129.0 million in 2022, then increased by 0.08% to $129.1 million in 2023, then gained by 20.82% to $156.0 million in 2024, then rose by 25.75% to $196.1 million in 2025, then climbed by 3.49% to $203.0 million in 2026.
- Business Quant data shows CYTK's Operating Expenses at $203.0 million in Q1 2026, $196.1 million in Q4 2025, and $168.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | 207.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 207.80 Mn |
| Mar 31, 2026 | 202.97 Mn |
| Dec 31, 2025 | 196.12 Mn |
| Sep 30, 2025 | 168.69 Mn |
| Jun 30, 2025 | 178.28 Mn |
| Mar 31, 2025 | 157.21 Mn |
| Dec 31, 2024 | 155.97 Mn |
| Sep 30, 2024 | 141.26 Mn |
| Jun 30, 2024 | 130.42 Mn |
| Mar 31, 2024 | 127.07 Mn |
| Dec 31, 2023 | 129.09 Mn |
| Sep 30, 2023 | 122.64 Mn |
| Jun 30, 2023 | 122.92 Mn |
| Mar 31, 2023 | 129.09 Mn |
| Dec 31, 2022 | 128.99 Mn |
| Sep 30, 2022 | 110.96 Mn |
| Jun 30, 2022 | 99.84 Mn |
| Mar 31, 2022 | 79.01 Mn |
| Dec 31, 2021 | 77.30 Mn |
| Sep 30, 2021 | 74.64 Mn |